The use of Hybrid models in bioprocess development can be dramatic. The model's ability to generate qualitative insights with limited data translates into significant operational benefits - find out how.
As innovation floods the Biopharma industry, innovation leads have more choices than ever. This fortunate problem creates a new challenge - how to select the best approach?